Regulatory News
Tuesday, July 26, 2016
BRIEF-Inovio Pharmaceuticals doses first subject in Zika vaccine clinical trial
* Inovio Pharmaceuticals doses first subject in Zika vaccine
clinical trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment